Latest Milestone Scientific (MLSS) Headlines
Post# of 46
Posted On: 03/10/2014 2:29:39 PM
Latest Milestone Scientific (MLSS) Headlines
Milestone Scientific Anticipates Significant Increase in Wand(R) Handpiece Sales in Second Half of 2014
Marketwire - Mon Mar 10, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Aseptico, its exclusive dental distributor, will now only sell Milestone's STA Wand® handpieces directly to dentists and will no longer sell through third-party distributors. As a result, the Company announced that it anticipates increased Wand® handpiece sales in the second half of 2014 due to the greater transparency and direct contact it will have with dentists through Aseptico.
Milestone Scientific Schedules 2013 Year-End Earnings Conference Call
Marketwire - Fri Mar 07, 10:10AM CST
Milestone Scientific, Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 8:30 a.m. Eastern Daylight Time on Thursday, March 13, 2014 to discuss the company's financial results for the fourth quarter and full year ending December 31, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific Closes a $150,000 Private Placement of Common Stock at $1.50 per Share
Marketwire - Thu Dec 05, 7:01AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it has closed on a $150,000 Private Placement offering of restricted shares of Common Stock at $1.50 per share to WDM Capital USA, an affiliate of Dom Maklerski WDM, S.A. This offering will result in the issuance of 100,000 shares of Common Stock.
Milestone Scientific Announces Its Milestone Medical Inc. Subsidiary Has Listed on the Warsaw Stock Exchange
Marketwire - Mon Dec 02, 7:02AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, is pleased to announce its Milestone Medical, Inc. subsidiary has successfully listed and commenced trading on the Warsaw Stock Exchange under the ticker "MMD" (WARSAW: MMD). This listing follows the recent financing conducted by WDM with $3 million raised from European investors for a post-money valuation of approximately $33 million.
Milestone Scientific Reports Third Quarter Financial Results and Provides Business Update
Marketwire - Tue Nov 12, 3:05PM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the three and nine months ended September 30, 2013.
Milestone Scientific Announces Its Milestone Medical Inc. Subsidiary Has Raised an Additional $1.5 Million From European Investors
Marketwire - Tue Nov 12, 6:50AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced its Milestone Medical Inc. subsidiary has sold an additional $1.5 million of its common stock in a private placement to one of the largest mutual fund management companies in Poland (with assets under management in excess of USD $5 billion). Closing of the transaction is subject to listing of the shares on the New Connect Market of the Warsaw Stock Exchange. WDM acted as offering agent and leading financial advisor on the transaction. As a result of this second tranche to the financing with European investors announced on October 30, 2013, Milestone Medical Inc. has raised a total of $3.0 million from European investors, representing a post-money valuation of approximately $33.0 million.
Milestone Scientific Schedules Third Quarter 2013 Earnings Conference Call
Marketwire - Mon Nov 11, 6:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 8:30 a.m. Eastern Time, on Wednesday, November 13, 2013 to discuss the company's financial results for the third quarter ending September 30, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific Announces Its Milestone Medical Inc. Subsidiary Has Raised $1.5 Million From European Investors
Marketwire - Wed Oct 30, 8:49AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced its Milestone Medical Inc. subsidiary has sold $1.5 million of its common stock in a private placement to European institutional and other investors. Closing of the transaction is subject to listing of the shares on the New Connect Market of the Warsaw Stock Exchange. WDM acted as offering agent and leading financial advisor on the transaction.
Milestone Scientific Announces Distribution Agreement With Henry Schein
Marketwire - Thu Aug 29, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced a distribution agreement with Henry Schein, Inc., the world's largest provider of health care products and services to medical, dental, and veterinary office-based practitioners. Under the agreement, Henry Schein will become the exclusive U.S. and Canadian distributor of Milestone's The Wand® handpiece associated with its CompuDent® instrument. The agreement does not apply to Milestone's existing distribution agreements relating to its STA Single Tooth Anesthesia System®.
Milestone Scientific Announces Financial Results for the Second Quarter of 2013
Marketwire - Thu Aug 08, 3:05PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced financial results and provided a business update for the three and six months ended June 30, 2013.
Milestone Scientific Schedules Second Quarter 2013 Earnings Conference Call
Marketwire - Thu Aug 01, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 4:30 p.m. Eastern Time, on Thursday, August 8, 2013 to discuss the company's financial results for the second quarter ending June 30, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific to Present at 1st Global Life Sciences Conference in Warsaw
Marketwire - Wed Jul 17, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Leonard Osser, Chief Executive Officer, Joseph D'Agostino, Chief Financial Officer & Chief Operating Officer, and Mark Hochman, D.D.S., Director of Clinical Affairs, will present at the upcoming 1st Global Life Sciences Conference in Warsaw on September 16-17, 2013 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland. A recording of the presentation will be posted on Milestone's website following the conference.
Milestone Scientific and Tri-anim Health Services Form Strategic Partnership to Introduce Precision Injection Technology
Marketwire - Tue Jul 09, 8:40AM CDT
Milestone Scientific Inc. (OTCQB: MLSS) ("Milestone"), a leading medical research and development company that designs and patents innovative injection technology, announced today that it has entered into a strategic partnership with Tri-anim Health Services, Inc. ("Tri-anim"), the nation's largest provider of specialty sales and distribution solutions for healthcare, with core competencies in respiratory medicine, anesthesia, NICU, ICU and the OR. Tri-anim is a unit of Sarnova Inc., a specialty distributor of healthcare products.
Milestone Scientific to Present at SeeThruEquity Second Annual Investor Conference Forum in New York
Marketwire - Fri May 31, 2:17PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that Joseph D'Agostino, Chief Financial Officer & Chief Operating Officer, will present at the upcoming SeeThruEquity Second Annual Investor Conference on June 4, 2013 at 2:30 p.m. Eastern Time at the Penn Club in New York City. A recording of the presentation will be posted on Milestone's website following the conference.
Milestone Scientific Schedules First Quarter 2013 Earnings Conference Call
Marketwire - Fri May 03, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that it will host a conference call at 8:30 A.M. Eastern Time, on Tuesday, May 7, 2013 to discuss the company's financial results for the first quarter ending March 31, 2013, as well as the Company's corporate progress and other meaningful developments.
SeeThruEquity Initiates Coverage on Milestone Scientific
Marketwire - Mon Apr 15, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that SeeThruEquity, an investment research firm, has initiated coverage on Milestone Scientific.
Milestone Scientific Announces Adoption of Its STA Instruments in Valencia College's Dental Hygiene Program
Marketwire - Tue Mar 19, 8:13AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that Valencia College will be implementing Milestone's STA Single Tooth Anesthesia System® (STA System) in their Dental Hygiene program.
Milestone Scientific Reports 30% Increase in Sales for the Fourth Quarter of 2012 and Provides Business Update
Marketwire - Wed Mar 13, 3:42PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced financial results for fourth quarter and full year ended December 31, 2012.
Milestone Scientific Announces the Use of Their STA Instruments in the Local Anesthesia for Dental Hygienist Certification Program
Marketwire - Tue Mar 05, 6:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that the University of Florida College of Dentistry will be implementing Milestone's STA Single Tooth Anesthesia System® (STA System) as part of its Local Anesthesia for Dental Hygienist curriculum/certification program.
Milestone Scientific Anticipates Significant Increase in Wand(R) Handpiece Sales in Second Half of 2014
Marketwire - Mon Mar 10, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Aseptico, its exclusive dental distributor, will now only sell Milestone's STA Wand® handpieces directly to dentists and will no longer sell through third-party distributors. As a result, the Company announced that it anticipates increased Wand® handpiece sales in the second half of 2014 due to the greater transparency and direct contact it will have with dentists through Aseptico.
Milestone Scientific Schedules 2013 Year-End Earnings Conference Call
Marketwire - Fri Mar 07, 10:10AM CST
Milestone Scientific, Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 8:30 a.m. Eastern Daylight Time on Thursday, March 13, 2014 to discuss the company's financial results for the fourth quarter and full year ending December 31, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific Closes a $150,000 Private Placement of Common Stock at $1.50 per Share
Marketwire - Thu Dec 05, 7:01AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it has closed on a $150,000 Private Placement offering of restricted shares of Common Stock at $1.50 per share to WDM Capital USA, an affiliate of Dom Maklerski WDM, S.A. This offering will result in the issuance of 100,000 shares of Common Stock.
Milestone Scientific Announces Its Milestone Medical Inc. Subsidiary Has Listed on the Warsaw Stock Exchange
Marketwire - Mon Dec 02, 7:02AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, is pleased to announce its Milestone Medical, Inc. subsidiary has successfully listed and commenced trading on the Warsaw Stock Exchange under the ticker "MMD" (WARSAW: MMD). This listing follows the recent financing conducted by WDM with $3 million raised from European investors for a post-money valuation of approximately $33 million.
Milestone Scientific Reports Third Quarter Financial Results and Provides Business Update
Marketwire - Tue Nov 12, 3:05PM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the three and nine months ended September 30, 2013.
Milestone Scientific Announces Its Milestone Medical Inc. Subsidiary Has Raised an Additional $1.5 Million From European Investors
Marketwire - Tue Nov 12, 6:50AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced its Milestone Medical Inc. subsidiary has sold an additional $1.5 million of its common stock in a private placement to one of the largest mutual fund management companies in Poland (with assets under management in excess of USD $5 billion). Closing of the transaction is subject to listing of the shares on the New Connect Market of the Warsaw Stock Exchange. WDM acted as offering agent and leading financial advisor on the transaction. As a result of this second tranche to the financing with European investors announced on October 30, 2013, Milestone Medical Inc. has raised a total of $3.0 million from European investors, representing a post-money valuation of approximately $33.0 million.
Milestone Scientific Schedules Third Quarter 2013 Earnings Conference Call
Marketwire - Mon Nov 11, 6:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 8:30 a.m. Eastern Time, on Wednesday, November 13, 2013 to discuss the company's financial results for the third quarter ending September 30, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific Announces Its Milestone Medical Inc. Subsidiary Has Raised $1.5 Million From European Investors
Marketwire - Wed Oct 30, 8:49AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced its Milestone Medical Inc. subsidiary has sold $1.5 million of its common stock in a private placement to European institutional and other investors. Closing of the transaction is subject to listing of the shares on the New Connect Market of the Warsaw Stock Exchange. WDM acted as offering agent and leading financial advisor on the transaction.
Milestone Scientific Announces Distribution Agreement With Henry Schein
Marketwire - Thu Aug 29, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced a distribution agreement with Henry Schein, Inc., the world's largest provider of health care products and services to medical, dental, and veterinary office-based practitioners. Under the agreement, Henry Schein will become the exclusive U.S. and Canadian distributor of Milestone's The Wand® handpiece associated with its CompuDent® instrument. The agreement does not apply to Milestone's existing distribution agreements relating to its STA Single Tooth Anesthesia System®.
Milestone Scientific Announces Financial Results for the Second Quarter of 2013
Marketwire - Thu Aug 08, 3:05PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced financial results and provided a business update for the three and six months ended June 30, 2013.
Milestone Scientific Schedules Second Quarter 2013 Earnings Conference Call
Marketwire - Thu Aug 01, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 4:30 p.m. Eastern Time, on Thursday, August 8, 2013 to discuss the company's financial results for the second quarter ending June 30, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific to Present at 1st Global Life Sciences Conference in Warsaw
Marketwire - Wed Jul 17, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Leonard Osser, Chief Executive Officer, Joseph D'Agostino, Chief Financial Officer & Chief Operating Officer, and Mark Hochman, D.D.S., Director of Clinical Affairs, will present at the upcoming 1st Global Life Sciences Conference in Warsaw on September 16-17, 2013 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland. A recording of the presentation will be posted on Milestone's website following the conference.
Milestone Scientific and Tri-anim Health Services Form Strategic Partnership to Introduce Precision Injection Technology
Marketwire - Tue Jul 09, 8:40AM CDT
Milestone Scientific Inc. (OTCQB: MLSS) ("Milestone"), a leading medical research and development company that designs and patents innovative injection technology, announced today that it has entered into a strategic partnership with Tri-anim Health Services, Inc. ("Tri-anim"), the nation's largest provider of specialty sales and distribution solutions for healthcare, with core competencies in respiratory medicine, anesthesia, NICU, ICU and the OR. Tri-anim is a unit of Sarnova Inc., a specialty distributor of healthcare products.
Milestone Scientific to Present at SeeThruEquity Second Annual Investor Conference Forum in New York
Marketwire - Fri May 31, 2:17PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that Joseph D'Agostino, Chief Financial Officer & Chief Operating Officer, will present at the upcoming SeeThruEquity Second Annual Investor Conference on June 4, 2013 at 2:30 p.m. Eastern Time at the Penn Club in New York City. A recording of the presentation will be posted on Milestone's website following the conference.
Milestone Scientific Schedules First Quarter 2013 Earnings Conference Call
Marketwire - Fri May 03, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that it will host a conference call at 8:30 A.M. Eastern Time, on Tuesday, May 7, 2013 to discuss the company's financial results for the first quarter ending March 31, 2013, as well as the Company's corporate progress and other meaningful developments.
SeeThruEquity Initiates Coverage on Milestone Scientific
Marketwire - Mon Apr 15, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that SeeThruEquity, an investment research firm, has initiated coverage on Milestone Scientific.
Milestone Scientific Announces Adoption of Its STA Instruments in Valencia College's Dental Hygiene Program
Marketwire - Tue Mar 19, 8:13AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that Valencia College will be implementing Milestone's STA Single Tooth Anesthesia System® (STA System) in their Dental Hygiene program.
Milestone Scientific Reports 30% Increase in Sales for the Fourth Quarter of 2012 and Provides Business Update
Marketwire - Wed Mar 13, 3:42PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced financial results for fourth quarter and full year ended December 31, 2012.
Milestone Scientific Announces the Use of Their STA Instruments in the Local Anesthesia for Dental Hygienist Certification Program
Marketwire - Tue Mar 05, 6:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that the University of Florida College of Dentistry will be implementing Milestone's STA Single Tooth Anesthesia System® (STA System) as part of its Local Anesthesia for Dental Hygienist curriculum/certification program.
(0)
(0)Milestone Scientific (MLSS) Stock Research Links
Scroll down for more posts ▼